Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch.

Sonnenberg FA, Burkman RT, Speroff L, Westhoff C, Hagerty CG.

Am J Obstet Gynecol. 2005 Jan;192(1):1-9.

PMID:
15671994
2.

Economics of reducing menstruation with trimonthly-cycle oral contraceptive therapy: comparison with standard-cycle regimens.

Braunstein JB, Hausfeld J, Hausfeld J, London A.

Obstet Gynecol. 2003 Oct;102(4):699-708.

PMID:
14550999
3.
4.

Costs and net health effects of contraceptive methods.

Sonnenberg FA, Burkman RT, Hagerty CG, Speroff L, Speroff T.

Contraception. 2004 Jun;69(6):447-59.

PMID:
15157789
5.

Medical care cost savings from adolescent contraceptive use.

Trussell J, Koenig J, Stewart F, Darroch JE.

Fam Plann Perspect. 1997 Nov-Dec;29(6):248-55, 295.

6.

Transdermal contraceptive patch--a new birth control option.

Banerjee S.

Issues Emerg Health Technol. 2001 Nov;(26):1-4. No abstract available.

PMID:
11902225
7.

The transdermal contraceptive patch: a new approach to hormonal contraception.

Burkman RT.

Int J Fertil Womens Med. 2002 Mar-Apr;47(2):69-76. Review.

PMID:
11991433
8.

Contraceptive use among solid organ transplant patients: a systematic review.

Paulen ME, Folger SG, Curtis KM, Jamieson DJ.

Contraception. 2010 Jul;82(1):102-12. doi: 10.1016/j.contraception.2010.02.007. Epub 2010 Mar 29. Review.

PMID:
20682148
9.

The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy.

Archer DF, Cullins V, Creasy GW, Fisher AC.

Contraception. 2004 Mar;69(3):189-95.

PMID:
14969665
10.

A clinical study of transdermal contraceptive patch in Thai adolescence women.

Piyasirisilp R, Taneepanichskul S.

J Med Assoc Thai. 2008 Feb;91(2):137-41.

PMID:
18389975
11.

Evra--a patch on oral contraception?

[No authors listed]

Drug Ther Bull. 2003 Dec;41(12):89-91. Review.

PMID:
14723093
12.

Long-term evaluation of the use of the transdermal contraceptive patch in adolescents.

Logsdon S, Richards J, Omar HA.

ScientificWorldJournal. 2004 Jul 8;4:512-6.

13.

Achieving cost-neutrality with long-acting reversible contraceptive methods.

Trussell J, Hassan F, Lowin J, Law A, Filonenko A.

Contraception. 2015 Jan;91(1):49-56. doi: 10.1016/j.contraception.2014.08.011. Epub 2014 Sep 6.

14.

Ortho Evra, a new contraceptive patch.

Sicat BL.

Pharmacotherapy. 2003 Apr;23(4):472-80. Review.

PMID:
12680477
15.

Cost-savings from the provision of specific contraceptive methods in 2009.

Foster DG, Biggs MA, Malvin J, Bradsberry M, Darney P, Brindis CD.

Womens Health Issues. 2013 Jul-Aug;23(4):e265-71. doi: 10.1016/j.whi.2013.05.004.

PMID:
23816157
16.

The social costs of inadequate contraception.

Koenig JD, Strauss MJ, Henneberry J, Wilson TG.

Int J Technol Assess Health Care. 1996 Summer;12(3):487-97.

PMID:
8840668
17.
18.

Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.

Devineni D, Skee D, Vaccaro N, Massarella J, Janssens L, LaGuardia KD, Leung AT.

J Clin Pharmacol. 2007 Apr;47(4):497-509.

PMID:
17389559
19.

The trimonthly combination oral contraceptive regimen: is it cost effective?

Schwartz JL, Creinin MD, Pymar HC.

Contraception. 1999 Nov;60(5):263-7.

PMID:
10717777
20.

Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study.

Fleischer K, van Vliet HA, Rosendaal FR, Rosing J, Tchaikovski S, Helmerhorst FM.

Thromb Res. 2009;123(3):429-35. doi: 10.1016/j.thromres.2008.04.022. Epub 2008 Sep 30.

PMID:
18829069

Supplemental Content

Support Center